Related Experiment Videos

Increased dose-intensity in small-cell lung cancer: a failed strategy?

D H Johnson, D P Carbone

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|November 24, 1999

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA.

ESMO open·2025

Vaping, Smoking and Lung Cancer Risk.

Journal of oncology research and therapy·2024

Genomic characterization of thymic epithelial tumors in a real-world dataset.

ESMO open·2023

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.

ESMO open·2021

Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Newly diagnosed patients with advanced non-small cell lung cancer: A clinical description of those with moderate to severe depressive symptoms.

Lung cancer (Amsterdam, Netherlands)·2019

See all related articles